Date: 10th January 2026 (PST)
Location: Marines’ Memorial Club, San Francisco, USA
#Sachs_OIF moves to align with JP Morgan Healthcare Week to enable greater investor participation. The forum offers a high-impact platform for partnering, licensing, and investment across oncology, with in-person and virtual formats.
Why It Matters
The OIF provides opportunities to:
- Meet pharma licensing teams, corporate & financial investors, and advisers
- Showcase innovations to an oncology-focused audience
- Join discussions on dealmaking trends (incl. Chinese deal flow)
- Network during the reception and pre-arranged 1:1 meetings
Event Highlights
Programme (10 Jan, PST) includes panels on:
- BioPharma Dealmaking in Oncology: What to expect in 2026
- Commercial Thinking in Early Programs at Pre-Commercial Biotechs
- Investing in Next-Gen ADCs & Bispecifics
- Advanced Immunotherapies
- Advances in Treating Multiple Myeloma
- Breakthroughs in KRAS- & EGFR-Targeted Precision Therapies
- Investor Roundtable
Meetings & Formats: In-person meetings & networking on 10 Jan; Virtual Meetings via Online Meeting System from 20–22 Jan 2026 (EST). Company showcases and panels will be recorded and available on-demand.
🔗 Learn more about the 11th Annual Oncology Innovation Forum
📬 Contact the organizers: [email protected]